Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer
Phase I Trial Of Adenoviral Vector Delivery Of The Human Interleukin-12 cDNA By Intratumoral Injection In Patients With Metastatic Colorectal Cancer To The Liver
Sponsor: Max Sung
Terminated
limited funding
Other terminated trials from Max Sung
More terminations from Max Sung
Other Colorectal Cancer trials with similar outcome
Listed as NCT00072098, this PHASE1 trial focuses on Colorectal Cancer and Metastatic Cancer and remains terminated or withdrawn. Sponsored by Max Sung, it has been updated 6 times since 2003, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE1
Status: Unknown Status → Terminated
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status PHASE1
First recorded
Sep 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Max Sung
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .